- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pfizer Inc (PFE)
NYSE
Symbol | Exchange | Currency | |||
|---|---|---|---|---|---|
| PFE | · | NYSE | · | USD | |
| PFE | · | Xetra | · | EUR | |
| PFECHF | · | Switzerland | · | CHF | |
| 1PFE | · | Milan | · | EUR | |
| PFE | · | Vienna | · | EUR | |
| PFEm | · | Buenos Aires | · | ARS | |
| PFE | · | Santiago | · | USD | |
| PFIZ34 | · | B3 | · | BRL | |
| PFE | · | Toronto | · | CAD | |
| PFE | · | Mexico | · | MXN | |
| PFECO | · | Colombia | · | COP | |
| PFEUS | · | Lima | · | USD | |
| PFE | · | Ukraine | · | UAH | |
| PFE | · | Frankfurt | · | EUR | |
| PFE | · | TradeGate | · | EUR | |
| PFE_KZ | · | KASE | · | USD | |
| PFE_KZTQBD | · | KASE | · | USD | |
| PFE | · | Hamburg | · | EUR | |
| PFE | · | CBOE Canada | · | CAD |
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.62
24.20
52 wk Range
23.11
28.75
PFE Comments
Compiled here, all relevant comments and discussions regarding the PFE stock. Please note that all comments included here have met Investing.com's Comment Guidelines.
Working hard to get a new yearly low. I guess they will let this current leadership continue to destroy this company.
1062244650
jumping ship. New leadership at the top may be a good thing. can not be much worse than the current leadership.
Nobody is talking about this high dividend company, I think PFE and At&T should be bought and forget for 20 yes to come.
Totally agree with you.
I'm afraid we will see $24 before we see $30. No real gains until changes at the top.
I think it will go up next as I expect $30
The only thing this stock has is Dividend And nothing can move it higher
Pfizer is a heavy rock. Good news doesn't change anything
not much reward for beating your earnings. nothing moves this stock in a positive trend.
wow i wait dividend day
It cant hold even at 27, let aline 30 Another bad year again They should change this management
I can't see 30 in Pfizer's future. Zero confidence in growth and direction of the company.
Absolutely correct
It cant even hold 27
30$ easy
I thing end of the year
It has to pass 28 and 29
yes
Lets see if this time can hold around $27
PFE $27.22 +2.76% at Friday's close! (Monthly R1 $27.23)
No matter what a good earning or good news, this stock always drop
I have it up 7.5% YTD.
Terrible, when the good news is coming, the price is dropping
PFE $26.65 +0.79% at Close!
never fails. always gives the gains back.
Pfizer is acquiring companies and licences here and there, expensive.
Impossible to overcome the 25-25 price point... 🫥
Dividend is reward for patience. Sell at $40-$45.
Is Board od directors looking at the price of this stock, how come they are not doing anything?!
I'm sure the CEO and his Executive Team got their huge annual bonuses. no growth until a change at the top.
Every day a bad news and CEO gets all that money, management needs to change I think stock is going to 24 I have 4000 shares stock here for 3 years The only think we have is Dividend If they cut Dividends we look at $20 stock
Another Down Grade for PFE The only thing we have is Dividend
Payout ratio losted at over 120%??! Is that sustainable?
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.